9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene

C288H179N25 — CID 158110325

IUPAC9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
SMILESc1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc7c6c6ccccc6n7-c6nc(-c7ccccc7)c7ccccc7n6)c5ccc43)c2)cc1.c1ccc(-c2ccc(-c3cccc(-n4c5ccccc5c5c6c7ccccc7n(-c7cccc8c7c7ccccc7n8-c7nc(-c8ccccc8)c8ccccc8n7)c6ccc54)c3)cc2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc7c6c6ccccc6n7-c6nc(-c7ccccc7)c7ccccc7n6)c5ccc43)c2)cc1.c1ccc(-c2nc(-n3c4ccccc4c4c(-n5c6ccccc6c6c7c8ccccc8n(-c8ccc9ccccc9c8)c7ccc65)cccc43)nc3ccccc23)cc1.c1ccc(-c2nc(-n3c4ccccc4c4c(-n5c6ccccc6c6c7c8ccccc8n(-c8cccc9ccccc89)c7ccc65)cccc43)nc3ccccc23)cc1
InChIInChI=1S/2C62H39N5.C56H35N5.2C54H33N5/c1-4-19-40(20-5-1)43-37-44(41-21-6-2-7-22-41)39-45(38-43)65-51-30-15-12-27-48(51)59-56(65)35-36-57-60(59)49-28-13-16-31-52(49)66(57)54-33-18-34-55-58(54)47-26-11-17-32-53(47)67(55)62-63-50-29-14-10-25-46(50)61(64-62)42-23-8-3-9-24-42;1-3-17-40(18-4-1)41-33-35-42(36-34-41)44-21-15-22-45(39-44)65-51-28-12-9-25-48(51)59-56(65)37-38-57-60(59)49-26-10-13-29-52(49)66(57)54-31-16-32-55-58(54)47-24-8-14-30-53(47)67(55)62-63-50-27-11-7-23-46(50)61(64-62)43-19-5-2-6-20-43;1-3-17-36(18-4-1)38-21-15-22-39(35-38)59-45-28-12-9-25-42(45)53-50(59)33-34-51-54(53)43-26-10-13-29-46(43)60(51)48-31-16-32-49-52(48)41-24-8-14-30-47(41)61(49)56-57-44-27-11-7-23-40(44)55(58-56)37-19-5-2-6-20-37;1-2-17-35(18-3-1)53-37-21-6-10-25-41(37)55-54(56-53)59-45-28-13-7-22-38(45)50-46(30-15-31-47(50)59)58-44-27-12-9-24-40(44)52-49(58)33-32-48-51(52)39-23-8-11-26-43(39)57(48)42-29-14-19-34-16-4-5-20-36(34)42;1-2-16-35(17-3-1)53-38-19-6-10-23-42(38)55-54(56-53)59-45-26-13-7-20-39(45)50-46(27-14-28-47(50)59)58-44-25-12-9-22-41(44)52-49(58)32-31-48-51(52)40-21-8-11-24-43(40)57(48)37-30-29-34-15-4-5-18-36(34)33-37/h2*1-39H;1-35H;2*1-33H
InChIKeyFQIVPKQOUQBNON-UHFFFAOYSA-N
MW3989.77 g/mol
LogP73.58
Rot. Bonds25

About 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene

9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene (PubChem CID 158110325) has the molecular formula C288H179N25 and a molecular weight of 3989.77 g/mol. Its IUPAC name is 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene.

Molecular Properties

Compound Name9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
PubChem CID158110325
Molecular FormulaC288H179N25
Molecular Weight3989.77 g/mol
Exact Mass3986.48
IUPAC Name9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
SMILESc1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc7c6c6ccccc6n7-c6nc(-c7ccccc7)c7ccccc7n6)c5ccc43)c2)cc1.c1ccc(-c2ccc(-c3cccc(-n4c5ccccc5c5c6c7ccccc7n(-c7cccc8c7c7ccccc7n8-c7nc(-c8ccccc8)c8ccccc8n7)c6ccc54)c3)cc2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc7c6c6ccccc6n7-c6nc(-c7ccccc7)c7ccccc7n6)c5ccc43)c2)cc1.c1ccc(-c2nc(-n3c4ccccc4c4c(-n5c6ccccc6c6c7c8ccccc8n(-c8ccc9ccccc9c8)c7ccc65)cccc43)nc3ccccc23)cc1.c1ccc(-c2nc(-n3c4ccccc4c4c(-n5c6ccccc6c6c7c8ccccc8n(-c8cccc9ccccc89)c7ccc65)cccc43)nc3ccccc23)cc1
InChIInChI=1S/2C62H39N5.C56H35N5.2C54H33N5/c1-4-19-40(20-5-1)43-37-44(41-21-6-2-7-22-41)39-45(38-43)65-51-30-15-12-27-48(51)59-56(65)35-36-57-60(59)49-28-13-16-31-52(49)66(57)54-33-18-34-55-58(54)47-26-11-17-32-53(47)67(55)62-63-50-29-14-10-25-46(50)61(64-62)42-23-8-3-9-24-42;1-3-17-40(18-4-1)41-33-35-42(36-34-41)44-21-15-22-45(39-44)65-51-28-12-9-25-48(51)59-56(65)37-38-57-60(59)49-26-10-13-29-52(49)66(57)54-31-16-32-55-58(54)47-24-8-14-30-53(47)67(55)62-63-50-27-11-7-23-46(50)61(64-62)43-19-5-2-6-20-43;1-3-17-36(18-4-1)38-21-15-22-39(35-38)59-45-28-12-9-25-42(45)53-50(59)33-34-51-54(53)43-26-10-13-29-46(43)60(51)48-31-16-32-49-52(48)41-24-8-14-30-47(41)61(49)56-57-44-27-11-7-23-40(44)55(58-56)37-19-5-2-6-20-37;1-2-17-35(18-3-1)53-37-21-6-10-25-41(37)55-54(56-53)59-45-28-13-7-22-38(45)50-46(30-15-31-47(50)59)58-44-27-12-9-24-40(44)52-49(58)33-32-48-51(52)39-23-8-11-26-43(39)57(48)42-29-14-19-34-16-4-5-20-36(34)42;1-2-16-35(17-3-1)53-38-19-6-10-23-42(38)55-54(56-53)59-45-26-13-7-20-39(45)50-46(27-14-28-47(50)59)58-44-25-12-9-22-41(44)52-49(58)32-31-48-51(52)40-21-8-11-24-43(40)57(48)37-30-29-34-15-4-5-18-36(34)33-37/h2*1-39H;1-35H;2*1-33H
InChIKeyFQIVPKQOUQBNON-UHFFFAOYSA-N
XLogP73.58
TPSA202.85 Ų
H-Bond Donors
H-Bond Acceptors25
Rotatable Bonds25
Heavy Atoms313
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003989.77
LogP ≤ 573.58
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1025

Analyze 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

9-(3,5-diphenylphenyl)-14-(4-phenylquinazolin-2-yl)-9,14-diazahexacyclo[11.11.0.02,10.03,8.015,24.018,23]tetracosa-1(13),2(10),3,5,7,11,15(24),16,18,20,22-undecaene
CID 135165803
7-[4-[4-[3-(9-phenylcarbazol-3-yl)phenyl]phenyl]quinazolin-2-yl]benzo[c]carbazole
CID 71109055
9,14-dinaphthalen-1-yl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9,14-dinaphthalen-2-yl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;5-phenyl-9,14-bis(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3(8),4,6,11,15,17,19-nonaene;5-phenyl-9-(3-phenylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3(8),4,6,11,15,17,19-nonaene
CID 162237950
9-(4-naphthalen-2-ylquinazolin-2-yl)-14-[3-(4-phenylquinazolin-2-yl)phenyl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
CID 134509632
14-phenyl-9-[4-(3-phenylphenyl)quinazolin-2-yl]-9,14-diazahexacyclo[11.11.0.02,10.03,8.015,24.018,23]tetracosa-1(13),2(10),3,5,7,11,15(24),16,18,20,22-undecaene
CID 135165864
14-(3,5-diphenylphenyl)-9-[4-(4-phenylphenyl)quinazolin-2-yl]-9,14-diazahexacyclo[11.11.0.02,10.03,8.015,24.016,21]tetracosa-1(13),2(10),3,5,7,11,15(24),16,18,20,22-undecaene
CID 135165926
2-benzo[c]carbazol-7-yl-5-[4-(3,5-diphenylphenyl)quinazolin-2-yl]benzo[b]carbazole
CID 146375215
7-(4-naphthalen-2-ylphenyl)-10-[9-(4-phenylquinazolin-2-yl)carbazol-3-yl]benzo[c]carbazole
CID 164784298
3-benzo[c]carbazol-7-yl-5-[4-(4-phenylphenyl)quinazolin-2-yl]benzo[b]carbazole
CID 146375569
3-[3-[2-[2-(9-benzo[c]carbazol-7-ylbenzo[c]carbazol-7-yl)quinazolin-4-yl]carbazol-9-yl]phenyl]-9-carbazol-9-yl-7-[4-(9-phenylcarbazol-2-yl)quinazolin-2-yl]benzo[c]carbazole
CID 166956013
7-(4-phenylphenyl)-10-[7-(4-phenylquinazolin-2-yl)benzo[c]carbazol-10-yl]benzo[c]carbazole;7-(4-phenylphenyl)-10-[9-(4-phenylquinazolin-2-yl)carbazol-3-yl]benzo[c]carbazole
CID 165103211
1-carbazol-9-yl-5-[4-(4-phenylphenyl)quinazolin-2-yl]benzo[b]carbazole
CID 155114247

Frequently Asked Questions

What is the IUPAC name of 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?
The IUPAC name of 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene (CID 158110325) is 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene.
What is the SMILES notation for 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?
The canonical SMILES for 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene is c1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc7c6c6ccccc6n7-c6nc(-c7ccccc7)c7ccccc7n6)c5ccc43)c2)cc1.c1ccc(-c2ccc(-c3cccc(-n4c5ccccc5c5c6c7ccccc7n(-c7cccc8c7c7ccccc7n8-c7nc(-c8ccccc8)c8ccccc8n7)c6ccc54)c3)cc2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc7c6c6ccccc6n7-c6nc(-c7ccccc7)c7ccccc7n6)c5ccc43)c2)cc1.c1ccc(-c2nc(-n3c4ccccc4c4c(-n5c6ccccc6c6c7c8ccccc8n(-c8ccc9ccccc9c8)c7ccc65)cccc43)nc3ccccc23)cc1.c1ccc(-c2nc(-n3c4ccccc4c4c(-n5c6ccccc6c6c7c8ccccc8n(-c8cccc9ccccc89)c7ccc65)cccc43)nc3ccccc23)cc1.
What is the InChIKey of 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?
The InChIKey is FQIVPKQOUQBNON-UHFFFAOYSA-N. The full InChI is InChI=1S/2C62H39N5.C56H35N5.2C54H33N5/c1-4-19-40(20-5-1)43-37-44(41-21-6-2-7-22-41)39-45(38-43)65-51-30-15-12-27-48(51)59-56(65)35-36-57-60(59)49-28-13-16-31-52(49)66(57)54-33-18-34-55-58(54)47-26-11-17-32-53(47)67(55)62-63-50-29-14-10-25-46(50)61(64-62)42-23-8-3-9-24-42;1-3-17-40(18-4-1)41-33-35-42(36-34-41)44-21-15-22-45(39-44)65-51-28-12-9-25-48(51)59-56(65)37-38-57-60(59)49-26-10-13-29-52(49)66(57)54-31-16-32-55-58(54)47-24-8-14-30-53(47)67(55)62-63-50-27-11-7-23-46(50)61(64-62)43-19-5-2-6-20-43;1-3-17-36(18-4-1)38-21-15-22-39(35-38)59-45-28-12-9-25-42(45)53-50(59)33-34-51-54(53)43-26-10-13-29-46(43)60(51)48-31-16-32-49-52(48)41-24-8-14-30-47(41)61(49)56-57-44-27-11-7-23-40(44)55(58-56)37-19-5-2-6-20-37;1-2-17-35(18-3-1)53-37-21-6-10-25-41(37)55-54(56-53)59-45-28-13-7-22-38(45)50-46(30-15-31-47(50)59)58-44-27-12-9-24-40(44)52-49(58)33-32-48-51(52)39-23-8-11-26-43(39)57(48)42-29-14-19-34-16-4-5-20-36(34)42;1-2-16-35(17-3-1)53-38-19-6-10-23-42(38)55-54(56-53)59-45-26-13-7-20-39(45)50-46(27-14-28-47(50)59)58-44-25-12-9-22-41(44)52-49(58)32-31-48-51(52)40-21-8-11-24-43(40)57(48)37-30-29-34-15-4-5-18-36(34)33-37/h2*1-39H;1-35H;2*1-33H.
What are the key properties of 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?
9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene has a molecular weight of 3989.77 g/mol, XLogP of 73.58, 25 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 9-(3,5-diphenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-1-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-naphthalen-2-yl-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-[3-(4-phenylphenyl)phenyl]-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenylphenyl)-14-[9-(4-phenylquinazolin-2-yl)carbazol-4-yl]-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene is sourced from PubChem (CID 158110325), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).